A sharpshooter for bacteria is in development to combat infections in the Intensive Care Unit
A sharpshooter for bacteria is in development to combat infections in the Intensive Care Unit. BiosparQ, a diagnostics company based in Leiden, thinks it can make an important contribution to the treatment of coronavirus COVID-19 patients in the Intensive Care Unit, but is urgently looking for partners. It concerns the analysis and combat of co-infections…